Pulse Biosciences, Inc. (PLSE) 是一家上市公司 属于 医疗保健 板块，经营于 Medical - Instruments & Supplies 行业. 公司总部位于 Miami, CA, 美国. 现任CEO为 Paul Arthur LaViolette.
PLSE 拥有 IPO日期为 2016-05-18, 75 名全职员工, 在 NASDAQ Capital Marke, 市值为 $1.37B.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
